| Name | 2-bromo-1,3-benzothiazol-6-ol |
|---|---|
| Synonyms |
2-Bromobenzothiazol-6-ol
2-bromo-6-hydroxybenzothiazole 2-bromobenzo[d]thiazol-6-ol 2-Bromo-6-Benzo[d]thiazolol |
| Density | 1.903g/cm3 |
|---|---|
| Boiling Point | 373.8ºC at 760 mmHg |
| Molecular Formula | C7H4BrNOS |
| Molecular Weight | 230.08200 |
| Flash Point | 179.9ºC |
| Exact Mass | 228.92000 |
| PSA | 61.36000 |
| LogP | 2.76440 |
| Index of Refraction | 1.768 |
| HS Code | 2934200090 |
|---|
|
~84%
808755-67-1 |
| Literature: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; CAI, Lisheng; PIKE, Victor W. Patent: WO2013/40183 A1, 2013 ; Location in patent: Paragraph 0062 ; |
|
~%
808755-67-1 |
| Literature: WO2013/40183 A1, ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2934200090 |
|---|---|
| Summary | 2934200090. other compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |